Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism (original) (raw)
References
Arteaga CL and Osborne K. . 1989 Cancer Res.49: 6237–6241.
Belfiore A, Costantino A, Frasca F, Pandini G, Mineo R, Vigneri P, Goldfine ID and Vigneri R. . 1996 Mol. Endocrinol.10: 1318–1326.
Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB. . 1996 Cancer Res.47: 943–946.
Cullen KJ, Allison A, Martire I, Ellis M and Singer C. . 1992a Breast Cancer Res. Treat.2: 21–29.
Cullen KJ, Lippman ME, Chow D, Hill S, Rosen N and Zwiebel JA. . 1992b Mol. Endocrinol.6: 91–100.
Dickson RB and Lippman M. . 1995 Endocrin. Rev.16: 559–565.
Ebina Y, Ellis L, Jarnaglin K, Edery M, Graf L, Clauser E, Ou JH, Masirz F, Kan YW, Goldfine ID, Roth RA and Rutter WJ. . 1985 Cell40: 747–758.
Enjoh T, Hizuka N, Perdue JF, Takano K, Fujiwara H, Higashihashi N, Marumoto Y, Fukuda I and Sakano K-I. . 1996 J. Clin. Endocrin. Metab.77: 510–517.
Forsayeth JR, Montemurro A, Maddux BA, DePirro R and Goldfine ID. . 1987 J. Biol. Chem.262: 4134–4140.
Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A and Vigneri R. . 1999 Mol. Cell. Biol.19: in press.
Frittitta L, Vigneri R, Stampfer MR and Goldfine ID. . 1995 J. Cell. Biochem.57: 666–669.
Ganderton RH, Stanley KK, Field CE, Coghlan MP, Soos MA and Siddle K. . 1987 Biochem. J.288: 195–205.
Giorgino F, Belfiore A, Milazzo G, Costantino A, Maddux B, Whittaker J, Goldfine ID and Vigneri R. . 1991 Mol. Endocrinol.5: 452–459.
Gustafson TA and Rutter WJ. . 1987 J. Biol. Chem.265: 18663–18667.
Jonas HA and Cox AJ. . 1992 Biochem. J.266: 737–742.
Jonas HA, Cox AJ and Harrison LC. . 1992 Biochem. J.257: 101–107.
Jonas HA, Eckardt GS and Clark S. . 1990 Endocrinology127: 1301–1309.
Kull FC, Jacobs S, Su YF, Svoboda ME, Van Wyk JJ and Cuatrecasas P. . 1987 J. Biol. Chem.258: 6561–6566.
Louvi A, Accili D and Efstratiadis A. . 1997 Dev. Biol.189: 33–48.
Mathieu MC, Clark GM, Allred DC, Goldfine ID and Vigneri R. . 1997 Proc. Assoc. Am. Phys.109: 565–571.
Milazzo G, Giorgino F, Damante G, Sung C, Stampfer MR, Vigneri R, Goldfine ID and Belfiore A. . 1992a Cancer Res.52: 3924–3930.
Milazzo G, Yip CC, Maddux BA, Vigneri R and Goldfine ID. . 1992b J. Clin. Invest.89: 899–908.
Morrione A, Valentinis B, Xu S-q, Yumet G, Louvi A, Efstratiadis A and Baserga R. . 1997 Proc. Natl. Acad. Sci. USA94: 3777–3782.
Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SAW, Ramasharma K, Marshall M and Li CH. . 1989 Mol. Endocrin.3: 1701–1709.
Papa V and Belfiore A. . 1996 J. Endocrin. Invest.19: 324–333.
Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, Frittitta L, Vannelli GB, Brand R, Goldfine ID and Vigneri R. . 1990 J. Clin. Invest.86: 1503–1510.
Podskalny JM, Rouiller DG, Grunberger G, Baxter RC, McElduff A and Gorden P. . 1986 J. Biol. Chem.261: 14076–14081.
Soos MA, Field CE, Lammers R, Ullrich A, Zhang B, Roth RA, Andersen AS, Kjeldsen T and Siddle K. . 1992 J. Biol. Chem.267: 12955–12963.
Steller MA, Delgado CH, Bartels CJ, Woodworth CD and Zou Z. . 1996 Cancer Res.56: 1761–1765.
Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M and Collins C. . 1986 EMBO J.5: 2503–2512.
Yamaguchi Y, Flier JS, Yokota A, Benecke H, Backer JM and Moller DE. . 1991 Endocrinology129: 2058–2066.